Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06004674 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Mar 2026 → Mar 2027
See other at-risk trials from Endeavor Health

Record History

  1. Primary and study completion pushed from Mar 2026 to Mar 2027v7
  2. Primary and study completion dates: Aug 2025 to Mar 2026v6
  3. Study Identification, Study Status, Oversight, Contacts/Locations, IPDSharingv5
  4. Start date changed from estimate of Dec 2023 to Dec 26, 2023v4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Sep 2023 to Dec 2023
    • Study sites: 0 to 1
    v3
  6. Start date: Aug 2023 to Sep 2023v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this randomized clinical trial is to evaluate if we can use placental pathology in a prior pregnancy which had an adverse outcome, such as early delivery, stillbirth, a baby born smaller than expected, or severe forms of high blood pressure during pregnancy, to guide treatment in the subsequent pregnancy and reduce risk of recurrent adverse pregnancy events. The main questions it aims to answer are: * Whether enoxaparin prevents recurrent adverse pregnancy outcomes among patients with a prior adverse pregnancy outcome that occurred in the setting of maternal vascular malperfusion (MVM). * If enoxaparin reduces the occurrence or severity of MVM among patients with a prior adverse pregnancy outcome that occurred in the setting of MVM.
Trial Details
NCT Number NCT06004674
Lead Sponsor Endeavor Health
Conditions
(from sponsor)		 Adverse Pregnancy Outcome
Related terms Abortion, Spontaneous, Pre-Eclampsia, Premature Birth, Stillbirth
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov